Minerva Surgical Inc. (UTRS)
NASDAQ (CM) NASDAQ (CM) Primary Summary
Minerva Surgical Inc. (UTRS) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has Minerva Surgical Inc. ever had a stock split?
Minerva Surgical Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Darin Hammers CEO | NASDAQ (CM) Exchange | 60343F205 CUSIP |
| US Country | 174 Employees | - Last Dividend | 2 Oct 2023 Last Split | 22 Oct 2021 IPO Date |
Overview
Minerva Surgical, Inc. is a company deeply immersed in the medical technology sector, with a particular focus on advancing minimally invasive surgical solutions designed specifically for women's uterine health care. Incorporated in 2008 and based in Santa Clara, California, the company has reached a commercial-stage status, emphasizing the development, manufacturing, and distribution of its revolutionary devices across the United States. Serving the needs of women through innovative medical treatments, Minerva Surgical has positioned itself as a key player in promoting enhanced healthcare outcomes within the realm of gynecology.
Products and Services
- Minerva ES Endometrial Ablation System
This system represents a breakthrough in endometrial ablation technology, specifically designed to provide a minimally invasive procedure for women experiencing heavy menstrual bleeding. By delivering precise, controlled energy to the endometrium, the system effectively reduces or stops bleeding, offering a significant improvement in the quality of life for many patients.
- Genesys HTA Endometrial Ablation System
Another pioneering device in the field of endometrial ablation, the Genesys HTA system, is engineered to treat the endometrium with a heated saline solution. This treatment method is characterized by its adaptability, allowing for personalized procedures that can accommodate various uterine shapes and sizes, thus maximizing patient safety and efficacy.
- Symphion Tissue Removal System
The Symphion system introduces a minimally invasive approach to uterine tissue removal that combines several innovative features: bladeless tissue resection, coagulation, continuous visualization, and intrauterine pressure monitoring. This integrated system ensures a high level of accuracy and safety, significantly enhancing surgical outcomes for procedures such as polypectomy and myomectomy.
- Resectr Tissue Resection Device
A handheld surgical tool, the Resectr device facilitates the hysteroscopic removal and diagnosis of endometrial polyps. It stands out for its simplicity and effectiveness, enabling physicians to perform polyp removal in a minimally invasive manner, with potential use in diverse medical settings from hospitals to physicians' offices.
